Reckitt Benckiser Group (RB) Given a GBX 5,000 Price Target by Jefferies Financial Group Analysts
Other research analysts have also recently issued research reports about the stock. Sanford C. Bernstein set a GBX 7,500 ($98.00) price objective on shares of Reckitt Benckiser Group and gave the company a buy rating in a research report on Monday. UBS Group reiterated a neutral rating and set a GBX 6,300 ($82.32) price objective (down previously from GBX 6,400 ($83.63)) on shares of Reckitt Benckiser Group in a research report on Friday, October 26th. JPMorgan Chase & Co. set a GBX 9,000 ($117.60) price objective on shares of Reckitt Benckiser Group and gave the company a buy rating in a research report on Wednesday, October 31st. Credit Suisse Group set a GBX 6,000 ($78.40) price objective on shares of Reckitt Benckiser Group and gave the company a sell rating in a research report on Monday, January 14th. Finally, Liberum Capital reiterated a buy rating and set a GBX 7,300 ($95.39) price objective on shares of Reckitt Benckiser Group in a research report on Monday, February 4th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and ten have issued a buy rating to the company. Reckitt Benckiser Group has an average rating of Hold and a consensus target price of GBX 6,832.78 ($89.28).
RB stock opened at GBX 6,140 ($80.23) on Monday. Reckitt Benckiser Group has a twelve month low of GBX 5,562 ($72.68) and a twelve month high of GBX 8,110.43 ($105.98).
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names.
Featured Article: Municipal Bonds
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.